Immunoglobulin purification

US9631008B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9631008-B2
Application numberUS-200913141306-A
CountryUS
Kind codeB2
Filing dateDec 18, 2009
Priority dateDec 22, 2008
Publication dateApr 25, 2017
Grant dateApr 25, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The current invention reports a method for purifying an immunoglobulin, wherein the method comprises applying an aqueous, buffered solution comprising an immunoglobulin in monomeric, in aggregated, and in fragmented form to an anion exchange chromatography material under conditions whereby the immunoglobulin in monomeric form does not bind to the anion exchange material, and recovering the immunoglobulin in monomeric form in the flow-through from the anion exchange chromatography material, whereby the buffered aqueous solution has a pH value of from 8.0 to 8.5. In one embodiment the anion exchange chromatography material is a membrane anion exchange chromatography material.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for obtaining an immunoglobulin in monomeric form, wherein the method comprises the following step: applying an aqueous, buffered solution comprising an immunoglobulin in monomeric and in aggregated form and immunoglobulin fragments to a membrane anion exchange chromatography material, wherein the aqueous, buffered solution has a pH value of pH 8.5, whereby the immunoglobulin depleted of immunoglobulin aggregates and immunoglobulin fragments is recovered from the flow-through of the membrane anion exchange chromatography material and thereby an immunoglobulin in monomeric form is obtained. 2. The method according to claim 1 , characterized in that said anion exchange chromatography material is a strong anion exchange chromatography material. 3. The method according to any one of the preceding claims, characterized in that said method comprises prior to step a) an additional protein A chromatography step or a HCIC chromatography step.

Assignees

Inventors

Classifications

  • Stabilisation, fragmentation · CPC title

  • against receptors for cytokines, lymphokines, interferons · CPC title

  • against the immunoglobulin superfamily · CPC title

  • Ion-exchange chromatography · CPC title

  • C07K16/065Primary

    Purification, fragmentation · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9631008B2 cover?
The current invention reports a method for purifying an immunoglobulin, wherein the method comprises applying an aqueous, buffered solution comprising an immunoglobulin in monomeric, in aggregated, and in fragmented form to an anion exchange chromatography material under conditions whereby the immunoglobulin in monomeric form does not bind to the anion exchange material, and recovering the immu…
Who is the assignee on this patent?
Pompiati Marc, Schaubmar Andreas, Hoffmann La Roche
What technology area does this patent fall under?
Primary CPC classification C07K16/065. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).